A New Chapter for MSD in the Philippines: Welcoming Mary Srethapakdi as Managing Director
November 5, 2026
MSD in the Philippines is entering a new chapter with the appointment of Mary Srethapakdi as Managing Director for the Philippines alongside her ongoing responsibility for MSD’s operations in Thailand. She succeeds Andreas Riedel who now serves as Managing Director for MSD Vietnam.
Srethapakdi brings more than 20 years of experience in the pharmaceutical and healthcare sectors including senior leadership roles in major healthcare companies and advisory work with healthcare organizations worldwide during her tenure at Boston Consulting Group. Since joining MSD as Managing Director for Thailand in 2021, she has focused on driving business growth and advancing initiatives aimed at improving patient access.
She holds a Bachelor of Arts in Biochemistry and a PhD in Molecular Biology from Cornell University, a foundation that supports her leadership across complex healthcare environments.
What This Means for MSD Philippines
With her expanded role, Srethapakdi will guide MSD’s efforts to expand access to innovative medicines and vaccines, strengthen partnerships across the healthcare ecosystem, and respond to the evolving needs of Filipino patients.
She shared that her priorities include deepening collaboration with healthcare stakeholders and improving patient access across the country, aligning closely with MSD’s long‑standing commitment to public health.
“I am honored to lead MSD in the Philippines at a critical juncture, when health is a pronounced priority in the public and private sectors,” she said.
A Legacy Rooted in Collaboration
MSD has been part of the Philippine healthcare landscape for over three decades, working with government, healthcare professionals, patient advocacy groups, industry partners, and health champions to advance medical innovation and patient care.
As Srethapakdi steps into her new role, she reinforces this mission:
“Today, we reaffirm this commitment to help bring broader access to innovative medicines and vaccines, with the aim of delivering better health outcomes for Filipino patients.”
Her leadership marks a promising new chapter that builds on MSD’s history of collaboration and looks ahead to even stronger partnerships for the health of communities across the country.